261 related articles for article (PubMed ID: 25473891)
1. Critical role of NF-κB in pancreatic cancer.
Prabhu L; Mundade R; Korc M; Loehrer PJ; Lu T
Oncotarget; 2014 Nov; 5(22):10969-75. PubMed ID: 25473891
[TBL] [Abstract][Full Text] [Related]
2. Advancement of NF-κB Signaling Pathway: A Novel Target in Pancreatic Cancer.
Pramanik KC; Makena MR; Bhowmick K; Pandey MK
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563089
[TBL] [Abstract][Full Text] [Related]
3. Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer.
Geismann C; Grohmann F; Dreher A; Häsler R; Rosenstiel P; Legler K; Hauser C; Egberts JH; Sipos B; Schreiber S; Linkermann A; Hassan Z; Schneider G; Schäfer H; Arlt A
Biochim Biophys Acta Mol Cell Res; 2017 May; 1864(5):782-796. PubMed ID: 28188806
[TBL] [Abstract][Full Text] [Related]
4. TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines.
Geismann C; Erhart W; Grohmann F; Schreiber S; Schneider G; Schäfer H; Arlt A
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29867042
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
6. L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression.
Kiefel H; Bondong S; Erbe-Hoffmann N; Hazin J; Riedle S; Wolf J; Pfeifer M; Arlt A; Schäfer H; Müerköster SS; Altevogt P
Oncogene; 2010 Aug; 29(34):4766-78. PubMed ID: 20543863
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.
Müerköster S; Arlt A; Sipos B; Witt M; Grossmann M; Klöppel G; Kalthoff H; Fölsch UR; Schäfer H
Cancer Res; 2005 Feb; 65(4):1316-24. PubMed ID: 15735017
[TBL] [Abstract][Full Text] [Related]
8. YEATS2 regulates the activation of TAK1/NF-κB pathway and is critical for pancreatic ductal adenocarcinoma cell survival.
Sheng H; Zheng F; Lan T; Chen HF; Xu CY; Wang SW; Weng YY; Xu LF; Zhang F
Cell Biol Toxicol; 2023 Jun; 39(3):1-16. PubMed ID: 34686948
[TBL] [Abstract][Full Text] [Related]
9. HOXA10 promote pancreatic cancer progression via directly activating canonical NF-κB signaling pathway.
Li J; Chang J; Wang J; Xu D; Yang M; Jiang Y; Zhang J; Jiang X; Sun Y
Carcinogenesis; 2022 Sep; 43(8):787-796. PubMed ID: 35553652
[TBL] [Abstract][Full Text] [Related]
10. Positive Crosstalk Between Hedgehog and NF-κB Pathways Is Dependent on KRAS Mutation in Pancreatic Ductal Adenocarcinoma.
Wang Y; Wang D; Dai Y; Kong X; Zhu X; Fan Y; Wang Y; Wu H; Jin J; Yao W; Gao J; Wang K; Xu H
Front Oncol; 2021; 11():652283. PubMed ID: 34046348
[TBL] [Abstract][Full Text] [Related]
11. IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.
Gao S; Sun Y; Zhang X; Hu L; Liu Y; Chua CY; Phillips LM; Ren H; Fleming JB; Wang H; Chiao PJ; Hao J; Zhang W
Cancer Res; 2016 Nov; 76(22):6543-6554. PubMed ID: 27659045
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution.
Hernández-Muñoz I; Skoudy A; Real FX; Navarro P
Pancreatology; 2008; 8(4-5):462-9. PubMed ID: 18724072
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.
Gunda V; Chhonker YS; Natesh NS; Raut P; Muniyan S; Wyatt TA; Murry DJ; Batra SK; Rachagani S
Biomed Pharmacother; 2021 Dec; 144():112312. PubMed ID: 34678726
[TBL] [Abstract][Full Text] [Related]
14. Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model.
Siddique HR; Liao DJ; Mishra SK; Schuster T; Wang L; Matter B; Campbell PM; Villalta P; Nanda S; Deng Y; Saleem M
Int J Cancer; 2012 Oct; 131(7):1720-31. PubMed ID: 22190076
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer.
Khurana N; Dodhiawala PB; Bulle A; Lim KH
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32961746
[TBL] [Abstract][Full Text] [Related]
16. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
[TBL] [Abstract][Full Text] [Related]
17. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome.
Su H; Yang F; Fu R; Trinh B; Sun N; Liu J; Kumar A; Baglieri J; Siruno J; Le M; Li Y; Dozier S; Nair A; Filliol A; Sinchai N; Rosenthal SB; Santini J; Metallo CM; Molina A; Schwabe RF; Lowy AM; Brenner D; Sun B; Karin M
Nature; 2022 Oct; 610(7931):366-372. PubMed ID: 36198801
[TBL] [Abstract][Full Text] [Related]
18. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
19. NF-κB and Pancreatic Cancer; Chapter and Verse.
Silke J; O'Reilly LA
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572737
[TBL] [Abstract][Full Text] [Related]
20. NF-κB as a target for pancreatic cancer therapy.
Carbone C; Melisi D
Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S1-10. PubMed ID: 22443181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
